JARROD ELSASS: Open Payments
NPI 1700328978 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,116 in 113 payments from 29 companies in 2025. Trend: 2023 $2,531 · 2024 $2,324 · 2025 $2,116
Food & beverage: $2,116
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $273 |
| PFIZER INC. | 10 | $208 |
| AstraZeneca Pharmaceuticals LP | 4 | $165 |
| GlaxoSmithKline, LLC. | 8 | $159 |
| Novo Nordisk Inc | 9 | $152 |
| Amgen Inc. | 13 | $152 |
| Otsuka America Pharmaceutical, Inc. | 7 | $140 |
| Lundbeck LLC | 6 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $71 |
Products named: REXULTI, NURTEC ODT, TRELEGY ELLIPTA, UBRELVY, FARXIGA, Wegovy, CAPLYTA, EVENITY.
Industry payments across VA — which companies pay providers there.
